Purchase Order HHSN272201501146P
Award Date 8/24/15
Potential Completion Date 9/23/15
Potential Value $25K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
North Bethesda, MD 20852, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract is for the delivery of EasySep Enrichment Kits, which are specialized cell separation products used in biomedical research, particularly for studies in areas like stem cell research, immunology, cancer, and infectious diseases. The...
- This is a $24,924.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract is for the supply of a "HUMAN NK KIT, CAT#19055", which are likely specialized biological products and research tools to support immunology and infectious disease research initiatives within the Department of Health and Human...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract, valued at $5,636.00, is for the delivery of EasySep Negative Human CD4 Kits, which are specialized cell isolation products used to support biomedical research. Stemcell Technologies Inc....
- This is a firm fixed-price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract is for the provision of the EasySep Human Pan-B Cell Enrichment Kit, a specialized cell separation product used to support biomedical research initiatives. The contract has a ceiling value of...
- This firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Stemcell Technologies Inc., a Canadian-owned for-profit organization, on August 6, 2019. The $24,069.90 contract is for the delivery of EasySep Negative Human CD4 Kits and EasySep Negative Human CD8 Kits, which are specialized biological products used in life sciences research. This sole-source award was made under the authority of 41 U.S.C....
- This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services' National Institutes of Health (NIH), to Stemcell Technologies Inc. for EASYSEP NEGATIVE HUMAN CD4 KITS. The $59,775.00 contract has a completion date of July 31, 2019 and was awarded on July 19, 2018 with no set-aside designation. Stemcell Technologies Inc. is a subsidiary of the Canadian company Stemcell Technologies, which...
- Stemcell Technologies Inc. received a $18,916.80 firm fixed-price purchase order from the National Institute of Allergy and Infectious Diseases (NIAID) on September 1, 2021, for EasySep Human Kits with an ultimate completion date of July 1, 2022. The contract was issued without a small business set-aside designation. The procurement was structured as an administrative de-obligation of unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a), with closure...
- This is a federal purchase order contract awarded by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The contract, valued at $23,828.70, is for the delivery of REAGENT MATERIALS - EASYSEP HUMAN IMMUNE CELL ISOLATION KITS by the prime contractor, Stemcell Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is a firm fixed-price purchase order with an ultimate...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $100,836.00 firm-fixed-price purchase order contract to Stemcell Technologies Inc., a Canadian-owned for-profit company, to provide EASYSEP ENRICHMENT KITS. This contract has a performance period from July 5, 2017 to July 5, 2018 and was not set aside for a particular type of small business. Stemcell Technologies Inc. is an established federal contractor...
- This is a federal contract award to Stemcell Technologies Inc., a Canadian biotechnology company, for the supply of an EasySep Negative Human CD4 Kit, catalog number 19052. The award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract has a ceiling value of $39,906.40 and is structured as a firm fixed price purchase order. The contract is...